SoftState Technologies

25/09/2024

New tracker finds 5.4M likely dementia cases 🧠

Researchers have created the first national system to monitor Alzheimer’s and other dementias in Medicare patients.

It shows that about 9% of beneficiaries may have dementia, and this number could triple by 2050. 😮

The system uses a set of 40 criteria to identify cases, aiming to improve diagnosis and care. New digital cognitive tests using AI are making early detection faster and more accurate, helping us understand and address these conditions better. 🙂

Illustration: Maura Losch/Axios
Source: https://www.axios.com/2024/09/04/dementia-alzheimers-medicare-surveillance-model

24/09/2024

Changing our perspective could change the future. 🧠

21/09/2024

On World Alzheimer’s Day 🧠, we reflect on the importance of brain health and the steps we can take to prevent dementia.

Research shows that adopting healthy habits—like staying active, managing stress, and maintaining social connections—can reduce the risk of Alzheimer’s by up to 40%.

It’s never too early to start protecting your brain for the future.

19/09/2024

Everything we thought about Alzheimer’s might be wrong.

For a long time, it was believed that Alzheimer’s is caused by harmful protein build-ups in the brain. But new research suggests something different: it might actually be the loss of a certain protein that leads to memory problems.

Instead of just focusing on removing these plaques, scientists now think boosting this important protein could help slow down or prevent cognitive decline. This fresh perspective could change how we approach Alzheimer’s treatment in the future.

18/09/2024

Recent studies have uncovered a potential game-changer in the early detection of Alzheimer's disease: blood tests that analyze microRNAs—tiny molecules that help control brain functions.

Researchers found that by measuring these microRNAs in the blood, we could predict the progression from mild cognitive impairment (MCI) to Alzheimer's. This breakthrough offers a more accessible and less invasive way to diagnose the disease years before symptoms appear, opening up new possibilities for early intervention and prevention.

This discovery could revolutionize how we detect Alzheimer's, helping doctors identify patients at risk much earlier and providing a better chance for treatments to be effective.

17/09/2024

😉

11/09/2024

Generative AI is reshaping software development by automating coding tasks through tools like code generation and copilots. While this offers increased efficiency, it also introduces challenges such as code validation and security risks.

However, integrating AI across development phases presents opportunities for innovation, prompting the need for careful navigation to maximize benefits and mitigate risks.

Source: Infoworld.com

10/09/2024

... and possibly an extra cup of coffee (or five)! ☕💻

05/09/2024

A new study published in The Lancet identifies vision loss and high cholesterol as two new potentially modifiable risk factors for Alzheimer's disease, adding them to a list of 12 previously known factors like physical inactivity, smoking, and high blood pressure.

Read more: https://www.cbsnews.com/news/new-risk-factors-for-alzheimers-what-to-do/

04/09/2024

🎉 We are excited to welcome Alexandru Mihai to the SoftState team as a Senior NodeJS Developer! 🎉

Alexandru joined us this year and is already making a big impact with his passion for analyzing ideas and needs to deliver solutions that create a meaningful experience for users. His drive for problem-solving and creating high-impact solutions makes him a perfect fit for our team.

In his free time, Alexandru loves staying up-to-date with the latest technologies by reading various technical resources and constantly learning new things.

Welcome to the team, Alexandru! 🚀

03/09/2024

29/08/2024

Linus Health researchers have developed a rapid, AI-assisted neuropsychological protocol that can be remotely administered and scored in just 10 minutes, specifically designed to assess neurocognitive functions associated with emerging neurodegenerative diseases.

Tested on patients from ambulatory care and memory clinics, this protocol combines traditional core measures with detailed error analysis and process variables.

The results indicate that this digital protocol can efficiently and accurately detect early signs of neurodegenerative illnesses, offering a reliable alternative to standard paper-and-pencil tests.

Learn more in Frontiers in Psychology: https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2024.1415629/full